Pneumococcal 13-Valent Conjugate Vaccine (Beijing Kexing Zhongwei Biotech)

13价肺炎球菌多糖结合疫苗（北京科兴中维）

Report date: 2026/05/12 20:00:17

Base Information

Drug NamePneumococcal 13-Valent Conjugate Vaccine (Beijing Kexing Zhongwei Biotech)
Drug Alias NameN/A
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Bacterial vaccineVaccines > Development/production technology > Conjugated vaccine +[4] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsPneumonia, PneumococcalPneumococcal InfectionsMeningitis, Pneumococcal +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesSinovac Life Sciences Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSinovac Biotech Co LtdSinovac Life Sciences Co Ltd
Inactive CompaniesN/A
Active IndicationsPneumonia, PneumococcalPneumococcal InfectionsMeningitis, Pneumococcal +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A